SlideShare a Scribd company logo
No
No
Yes
No
Black
JNC 8 Hypertension Guideline Algorithm
Lifestyle changes:
• Smoking Cessation
• Control blood glucose and lipids
• Diet
Eat healthy (i.e., DASH diet)
Moderate alcohol consumption
Reduce sodium intake to no
more than 2,400 mg/day
• Physical activity
Moderate-to-vigorous activity
3-4 days a week averaging 40
min per session.
Adult aged ≥ 18 years with HTN
Implement lifestyle modifications
Set BP goal, initiate BP-lowering medication based on algorithm
General Population
(no diabetes or CKD) Diabetes or CKD present
Age ≥ 60 years Age < 60 years All Ages
Diabetes present
No CKD
All Ages and Races
CKD present with or
without diabetes
BP Goal
< 150/90
BP Goal
< 140/90
BP Goal
< 140/90
BP Goal
< 140/90
Nonblack
Yes
Initiate thiazide or CCB,
alone or combo
Initiate ACEI or ARB,
alone or combo
w/another class
Reinforce lifestyle and adherence
Titrate medications to maximum doses or consider adding another medication (ACEI, ARB, CCB, Thiazide)
At blood pressure goal?
Reinforce lifestyle and adherence
Add a medication class not already selected (i.e. beta blocker, aldosterone antagonist, others) and titrate
above medications to max (see back of card)
Initiate thiazide, ACEI, ARB,
or CCB, alone or in combo
Reinforce lifestyle and adherence
Titrate meds to maximum doses, add another med and/or refer to hypertension specialist
Yes
Continue tx and monitoring
Initial Drugs of Choice for Hypertension
• ACE inhibitor (ACEI)
• Angiotensin receptor blocker (ARB)
• Thiazide diuretic
• Calcium channel blocker (CCB)
At blood pressure goal?
Strategy Description
A Start one drug, titrate to maximum
dose, and then add a second drug.
B Start one drug, then add a second
drug before achieving max dose of
first
C Begin 2 drugs at same time, as
separate pills or combination pill.
Initial combination therapy is
recommended if BP is greater than
20/10mm Hg above goal
At blood pressure goal?
Reference: James PA, Ortiz E, et al. 2014 evidence-based guideline for the management
of high blood pressure in adults: (JNC8). JAMA. 2014 Feb 5;311(5):507-20
Card developed by Cole Glenn, Pharm.D. & James L Taylor, Pharm.D.
Compelling Indications
Indication Treatment Choice
Heart Failure ACEI/ARB + BB + diuretic + spironolactone
Post –MI/Clinical CAD ACEI/ARB AND BB
CAD ACEI, BB, diuretic, CCB
Diabetes ACEI/ARB, CCB, diuretic
CKD ACEI/ARB
Recurrent stroke prevention ACEI, diuretic
Pregnancy labetolol (first line), nifedipine, methyldopa
Beta-1 Selective Beta-blockers – possibly safer in patients
with COPD, asthma, diabetes, and peripheral vascular
disease:
• metoprolol
• bisoprolol
• betaxolol
• acebutolol
Drug Class Agents of Choice Comments
Diuretics HCTZ 12.5-50mg, chlorthalidone 12.5-25mg, indapamide 1.25-2.5mg
triamterene 100mg
K+ sparing – spironolactone 25-50mg, amiloride 5-10mg, triamterene
100mg
furosemide 20-80mg twice daily, torsemide 10-40mg
Monitor for hypokalemia
Most SE are metabolic in nature
Most effective when combined w/ ACEI
Stronger clinical evidence w/chlorthalidone
Spironolactone - gynecomastia and hyperkalemia
Loop diuretics may be needed when GFR <40mL/min
ACEI/ARB ACEI: lisinopril, benazapril, fosinopril and quinapril 10-40mg, ramipril 5-
10mg, trandolapril 2-8mg
ARB: candesartan 8-32mg, valsartan 80-320mg, losartan 50-100mg,
olmesartan 20-40mg, telmisartan 20-80mg
SE: Cough (ACEI only), angioedema (more with ACEI),
hyperkalemia
Losartan lowers uric acid levels; candesartan may
prevent migraine headaches
Beta-Blockers metoprolol succinate 50-100mg and tartrate 50-100mg twice daily,
nebivolol 5-10mg, propranolol 40-120mg twice daily, carvedilol 6.25-25mg
twice daily, bisoprolol 5-10mg, labetalol 100-300mg twice daily,
Not first line agents – reserve for post-MI/CHF
Cause fatigue and decreased heart rate
Adversely affect glucose; mask hypoglycemic awareness
Calcium channel
blockers
Dihydropyridines: amlodipine 5-10mg, nifedipine ER 30-90mg,
Non-dihydropyridines: diltiazem ER 180-360 mg, verapamil 80-120mg 3
times daily or ER 240-480mg
Cause edema; dihydropyridines may be safely combined
w/ B-blocker
Non-dihydropyridines reduce heart rate and proteinuria
Vasodilators hydralazine 25-100mg twice daily, minoxidil 5-10mg
terazosin 1-5mg, doxazosin 1-4mg given at bedtime
Hydralazine and minoxidil may cause reflex tachycardia
and fluid retention – usually require diuretic + B-blocker
Alpha-blockers may cause orthostatic hypotension
Centrally-acting
Agents
clonidine 0.1-0.2mg twice daily, methyldopa 250-500mg twice daily
guanfacine 1-3mg
Clonidine available in weekly patch formulation for
resistant hypertension
Hypertension Treatment

More Related Content

DOCX
Algoritma Terapi HT.docx
PPTX
Jnc8 140131223904-phpapp02
DOCX
Hypertension Management
PPTX
Hypertension
PPTX
Hypertension
PPTX
Joint national committe 7
PPTX
Overview of the Medical Management of High Blood Pressure in Adults
PPT
Comb treatment-of-ht
Algoritma Terapi HT.docx
Jnc8 140131223904-phpapp02
Hypertension Management
Hypertension
Hypertension
Joint national committe 7
Overview of the Medical Management of High Blood Pressure in Adults
Comb treatment-of-ht

Similar to jnc-8-hypertension-guideline-algorithm.pdf (20)

PDF
combinatintherapyhypertension-baliga.pdf
PPTX
Combination Therapy In Hypertension - Dr Vivek Baliga Presentation
PPT
JNC-8.ppt
PPT
HT guideline management97
PPT
Hypertension 2014
PPTX
Mellss med hypertension
PPTX
Pharmacotherapy of hypertension
PPT
1.6.2 Pharmacologic Treatment
PDF
M3 - Hypertension
PPTX
Template Clinical Case 1 - hypertension.pptx
PPTX
PPT
Treatment of Hypertension YAKES.ppt
PDF
Hypertension and its update in treatment
PPTX
hypertension management guidelines standard
PDF
Achieving Blood Pressure Goal: From Clinical Trial into Real-World Data
PPTX
Hypertension
PPTX
Hypertension
PPTX
1 Drugs for Hypertension.pptx
PPTX
lincoln surgical presentation
combinatintherapyhypertension-baliga.pdf
Combination Therapy In Hypertension - Dr Vivek Baliga Presentation
JNC-8.ppt
HT guideline management97
Hypertension 2014
Mellss med hypertension
Pharmacotherapy of hypertension
1.6.2 Pharmacologic Treatment
M3 - Hypertension
Template Clinical Case 1 - hypertension.pptx
Treatment of Hypertension YAKES.ppt
Hypertension and its update in treatment
hypertension management guidelines standard
Achieving Blood Pressure Goal: From Clinical Trial into Real-World Data
Hypertension
Hypertension
1 Drugs for Hypertension.pptx
lincoln surgical presentation
Ad

Recently uploaded (20)

PPTX
LUNG ABSCESS - respiratory medicine - ppt
PPT
OPIOID ANALGESICS AND THEIR IMPLICATIONS
PPT
genitourinary-cancers_1.ppt Nursing care of clients with GU cancer
PDF
Medical Evidence in the Criminal Justice Delivery System in.pdf
PPTX
NEET PG 2025 Pharmacology Recall | Real Exam Questions from 3rd August with D...
PDF
شيت_عطا_0000000000000000000000000000.pdf
PPTX
Imaging of parasitic D. Case Discussions.pptx
PPTX
Fundamentals of human energy transfer .pptx
PPTX
CEREBROVASCULAR DISORDER.POWERPOINT PRESENTATIONx
PPTX
POLYCYSTIC OVARIAN SYNDROME.pptx by Dr( med) Charles Amoateng
PDF
NEET PG 2025 | 200 High-Yield Recall Topics Across All Subjects
PPTX
SKIN Anatomy and physiology and associated diseases
PPTX
Note on Abortion.pptx for the student note
PPTX
History and examination of abdomen, & pelvis .pptx
PPTX
ca esophagus molecula biology detailaed molecular biology of tumors of esophagus
PPT
STD NOTES INTRODUCTION TO COMMUNITY HEALT STRATEGY.ppt
PPT
ASRH Presentation for students and teachers 2770633.ppt
PDF
Therapeutic Potential of Citrus Flavonoids in Metabolic Inflammation and Ins...
PDF
Handout_ NURS 220 Topic 10-Abnormal Pregnancy.pdf
PPTX
surgery guide for USMLE step 2-part 1.pptx
LUNG ABSCESS - respiratory medicine - ppt
OPIOID ANALGESICS AND THEIR IMPLICATIONS
genitourinary-cancers_1.ppt Nursing care of clients with GU cancer
Medical Evidence in the Criminal Justice Delivery System in.pdf
NEET PG 2025 Pharmacology Recall | Real Exam Questions from 3rd August with D...
شيت_عطا_0000000000000000000000000000.pdf
Imaging of parasitic D. Case Discussions.pptx
Fundamentals of human energy transfer .pptx
CEREBROVASCULAR DISORDER.POWERPOINT PRESENTATIONx
POLYCYSTIC OVARIAN SYNDROME.pptx by Dr( med) Charles Amoateng
NEET PG 2025 | 200 High-Yield Recall Topics Across All Subjects
SKIN Anatomy and physiology and associated diseases
Note on Abortion.pptx for the student note
History and examination of abdomen, & pelvis .pptx
ca esophagus molecula biology detailaed molecular biology of tumors of esophagus
STD NOTES INTRODUCTION TO COMMUNITY HEALT STRATEGY.ppt
ASRH Presentation for students and teachers 2770633.ppt
Therapeutic Potential of Citrus Flavonoids in Metabolic Inflammation and Ins...
Handout_ NURS 220 Topic 10-Abnormal Pregnancy.pdf
surgery guide for USMLE step 2-part 1.pptx
Ad

jnc-8-hypertension-guideline-algorithm.pdf

  • 1. No No Yes No Black JNC 8 Hypertension Guideline Algorithm Lifestyle changes: • Smoking Cessation • Control blood glucose and lipids • Diet Eat healthy (i.e., DASH diet) Moderate alcohol consumption Reduce sodium intake to no more than 2,400 mg/day • Physical activity Moderate-to-vigorous activity 3-4 days a week averaging 40 min per session. Adult aged ≥ 18 years with HTN Implement lifestyle modifications Set BP goal, initiate BP-lowering medication based on algorithm General Population (no diabetes or CKD) Diabetes or CKD present Age ≥ 60 years Age < 60 years All Ages Diabetes present No CKD All Ages and Races CKD present with or without diabetes BP Goal < 150/90 BP Goal < 140/90 BP Goal < 140/90 BP Goal < 140/90 Nonblack Yes Initiate thiazide or CCB, alone or combo Initiate ACEI or ARB, alone or combo w/another class Reinforce lifestyle and adherence Titrate medications to maximum doses or consider adding another medication (ACEI, ARB, CCB, Thiazide) At blood pressure goal? Reinforce lifestyle and adherence Add a medication class not already selected (i.e. beta blocker, aldosterone antagonist, others) and titrate above medications to max (see back of card) Initiate thiazide, ACEI, ARB, or CCB, alone or in combo Reinforce lifestyle and adherence Titrate meds to maximum doses, add another med and/or refer to hypertension specialist Yes Continue tx and monitoring Initial Drugs of Choice for Hypertension • ACE inhibitor (ACEI) • Angiotensin receptor blocker (ARB) • Thiazide diuretic • Calcium channel blocker (CCB) At blood pressure goal? Strategy Description A Start one drug, titrate to maximum dose, and then add a second drug. B Start one drug, then add a second drug before achieving max dose of first C Begin 2 drugs at same time, as separate pills or combination pill. Initial combination therapy is recommended if BP is greater than 20/10mm Hg above goal At blood pressure goal? Reference: James PA, Ortiz E, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: (JNC8). JAMA. 2014 Feb 5;311(5):507-20 Card developed by Cole Glenn, Pharm.D. & James L Taylor, Pharm.D.
  • 2. Compelling Indications Indication Treatment Choice Heart Failure ACEI/ARB + BB + diuretic + spironolactone Post –MI/Clinical CAD ACEI/ARB AND BB CAD ACEI, BB, diuretic, CCB Diabetes ACEI/ARB, CCB, diuretic CKD ACEI/ARB Recurrent stroke prevention ACEI, diuretic Pregnancy labetolol (first line), nifedipine, methyldopa Beta-1 Selective Beta-blockers – possibly safer in patients with COPD, asthma, diabetes, and peripheral vascular disease: • metoprolol • bisoprolol • betaxolol • acebutolol Drug Class Agents of Choice Comments Diuretics HCTZ 12.5-50mg, chlorthalidone 12.5-25mg, indapamide 1.25-2.5mg triamterene 100mg K+ sparing – spironolactone 25-50mg, amiloride 5-10mg, triamterene 100mg furosemide 20-80mg twice daily, torsemide 10-40mg Monitor for hypokalemia Most SE are metabolic in nature Most effective when combined w/ ACEI Stronger clinical evidence w/chlorthalidone Spironolactone - gynecomastia and hyperkalemia Loop diuretics may be needed when GFR <40mL/min ACEI/ARB ACEI: lisinopril, benazapril, fosinopril and quinapril 10-40mg, ramipril 5- 10mg, trandolapril 2-8mg ARB: candesartan 8-32mg, valsartan 80-320mg, losartan 50-100mg, olmesartan 20-40mg, telmisartan 20-80mg SE: Cough (ACEI only), angioedema (more with ACEI), hyperkalemia Losartan lowers uric acid levels; candesartan may prevent migraine headaches Beta-Blockers metoprolol succinate 50-100mg and tartrate 50-100mg twice daily, nebivolol 5-10mg, propranolol 40-120mg twice daily, carvedilol 6.25-25mg twice daily, bisoprolol 5-10mg, labetalol 100-300mg twice daily, Not first line agents – reserve for post-MI/CHF Cause fatigue and decreased heart rate Adversely affect glucose; mask hypoglycemic awareness Calcium channel blockers Dihydropyridines: amlodipine 5-10mg, nifedipine ER 30-90mg, Non-dihydropyridines: diltiazem ER 180-360 mg, verapamil 80-120mg 3 times daily or ER 240-480mg Cause edema; dihydropyridines may be safely combined w/ B-blocker Non-dihydropyridines reduce heart rate and proteinuria Vasodilators hydralazine 25-100mg twice daily, minoxidil 5-10mg terazosin 1-5mg, doxazosin 1-4mg given at bedtime Hydralazine and minoxidil may cause reflex tachycardia and fluid retention – usually require diuretic + B-blocker Alpha-blockers may cause orthostatic hypotension Centrally-acting Agents clonidine 0.1-0.2mg twice daily, methyldopa 250-500mg twice daily guanfacine 1-3mg Clonidine available in weekly patch formulation for resistant hypertension Hypertension Treatment